Trial intelligence / Profile preview

Clinoleic vs Intralipid in preterm infants receiving parenteral nutrition

2004-001653-28Phase 4

Sponsor
Leeds Teaching Hospitals NHS Trust
Start
Sep 2005
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of Clinoleic in preterm birth (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Urine prostaglandin metabolite concentration.

02

Drugs

Clinoleic
03

Conditions

preterm birth

Beyond the preview

Go deeper on 2004-001653-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001653-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call